Samrat Pharmachem Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹388.1
- Today's High:
- ₹409.7
- Open Price:
- ₹409.7
- 52W Low:
- ₹332
- 52W High:
- ₹1248.9183
- Prev. Close:
- ₹404.25
- Volume:
- 11461
Company Statistics
- Market Cap.:
- ₹355.32 million
- Book Value:
- 78.459
- Revenue TTM:
- ₹1.38 billion
- Operating Margin TTM:
- 4.05%
- Gross Profit TTM:
- ₹101.71 million
- Profit Margin:
- 2.3%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Samrat Pharmachem Limited had its IPO on under the ticker symbol 530125.
The company operates in the Other sector and Other industry. Samrat Pharmachem Limited has a staff strength of 0 employees.
Stock update
Shares of Samrat Pharmachem Limited opened at ₹409.7 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹388.1 - ₹409.7, and closed at ₹397.2.
This is a -1.74% slip from the previous day's closing price.
A total volume of 11,461 shares were traded at the close of the day’s session.
In the last one week, shares of Samrat Pharmachem Limited have slipped by -1.51%.
Samrat Pharmachem Limited's Key Ratios
Samrat Pharmachem Limited has a market cap of ₹355.32 million, indicating a price to book ratio of 1.5403 and a price to sales ratio of 0.2516.
In the last 12-months Samrat Pharmachem Limited’s revenue was ₹1.38 billion with a gross profit of ₹101.71 million and an EBITDA of ₹60.11 million. The EBITDA ratio measures Samrat Pharmachem Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Samrat Pharmachem Limited’s operating margin was 4.05% while its return on assets stood at 0% with a return of equity of 0%.
In Q2, Samrat Pharmachem Limited’s quarterly earnings growth was a negative -57.4% while revenue growth was a negative 0.7%.
Samrat Pharmachem Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 7.018
- PEG
Its diluted EPS in the last 12-months stands at ₹10.239 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Samrat Pharmachem Limited’s profitability.
Samrat Pharmachem Limited stock is trading at a EV to sales ratio of 0.3028 and a EV to EBITDA ratio of 5.4106. Its price to sales ratio in the trailing 12-months stood at 0.2516.
Samrat Pharmachem Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.16 billion
- Total Liabilities
- ₹527.53 million
- Operating Cash Flow
- ₹-30050000.00
- Capital Expenditure
- ₹13.60 million
- Dividend Payout Ratio
- 0%
Samrat Pharmachem Limited ended 2024 with ₹1.16 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.16 billion while shareholder equity stood at ₹631.43 million.
Samrat Pharmachem Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹527.53 million in other current liabilities, 30897000.00 in common stock, ₹600.54 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹294000.00 and cash and short-term investments were ₹119.05 million. The company’s total short-term debt was ₹186,593,000 while long-term debt stood at ₹0.00.
Samrat Pharmachem Limited’s total current assets stands at ₹986.15 million while long-term investments were ₹0 and short-term investments were ₹139000.00. Its net receivables were ₹512.37 million compared to accounts payable of ₹0 and inventory worth ₹325.28 million.
In 2024, Samrat Pharmachem Limited's operating cash flow was ₹-30050000.00 while its capital expenditure stood at ₹13.60 million.
Comparatively, Samrat Pharmachem Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹397.2
- 52-Week High
- ₹1248.9183
- 52-Week Low
- ₹332
- Analyst Target Price
- ₹
Samrat Pharmachem Limited stock is currently trading at ₹397.2 per share. It touched a 52-week high of ₹1248.9183 and a 52-week low of ₹1248.9183. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹421.55 and 200-day moving average was ₹534.36 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6434.1% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Samrat Pharmachem Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Samrat Pharmachem Limited manufactures and sells pharmaceutical chemicals in India. It offers iodine salts and bromines salts, as well as iodine derivatives for industries, such as pharmaceuticals, chemicals, food, fertilizers, salt, etc. The company also exports its products worldwide. Samrat Pharmachem Limited was founded in 1992 and is based in Mumbai, India.